PHENYTOIN
Tonic-clonic Seizure
Emory UniversitySmall moleculePhase 4 / ApprovedDormant
B
61/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 46/ 100
- Competitive Position
- 95/ 100
Competitive context
5 Active assets in the Tonic-clonic Seizure cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
LAMOTRIGINE GlaxoSmithKline | Phase 4 | BBB |
Keppra Emory University | Phase 4 | BB |
Topamax GlaxoSmithKline | Phase 3 | BB |
MIDAZOLAM Pakistan Air Force (PAF) Hospital Islamabad | Phase 4 | BB |
Pregabalin Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | Phase 3 | BB |
View all 12 →
Same molecule, other indications
PHENYTOIN is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →